Building Toward “Unicorn” Status

Backed by accelerating market demand, breakthrough data architecture, and a seasoned management team.
100k+
Correlated, longitudinal RWE datapoints
75+
Diagnosis/treatment-specific Observational Protocols
3x
Year-over-year global growth
RegenMed is positioned to become the leading real-world evidence network — a trillion-dollar category for the next era of AI-driven healthcare.

A Leadership Team That Knows
How to Hyperscale

Leadership with deep experience in healthcare, enterprise software, and data systems

Michael P. Tierney

Co-Founder, CEO
Senior board and management positions, public and private companies.  Multiple international  successful exits. AMEX, Lehman, Omnicom, Taleo (sale to Oracle)

J. William Futrell, M.D.

Co-Founder. Chmn Emeritus
Fmr Chief, UPMC Plastic Surgery, AAPS President, +200 peer-reviewed articles. Multiple patents, co-founded businesses.

Dolph Courchaine

CITO
30 years senior level IT experience. WellMed. Geisinger Health. Optum/United Health Group

Laura Prey

Director
+30 years senior-level IT experience in healthcare, insurance, financial industries. WPS Insurance, Thrivent, Optum

Bert Mandelbaum, M.D.

C/SAB Member
Internationally recognized orthopedics thought leader.  Board, Cedars-Sinai Kerlan-Jobe.  Major League Soccer, USA Gymnastics, FIFA.

Claude. T. Moorman, M.D.

C/SAB Member
President, Atrium Musculoskeletal Institute. Chair, Dept. Orthopaedic Surgery.  Author, + 150 publications.  Neer Award for excellence in research.  Multiple NFL, collegiate athletic programs.

Kenneth R. Zaslav, M.D.

C/SAB Member
Director, Northwell Regenerative Orthopedic Medicine. Past President, ICRS.  Leadership, Biologic Association.  Former Clinical Professor Orthopedic Surgery VCU/Medical College of Virginia

Keith Hanna

IPRD Solutions, Data Architecture Partner
Senior positions, Sarnoff, SRI.  Multiple governmental, private and major foundation healthcare projects.  +25 publications, +100 patents, multiple awards

Why RegenMed Wins

RegenMed’s federated architecture and patented real-world evidence engine create durable, multi-layered competitive moats.
High Integrity RWE Engine
Produces structured, longitudinal datasets that are more complete and trustworthy than traditional EHR or claims feeds.
Federated Architecture
Captures provider data where it lives, eliminating central bottlenecks and making the network easier to adopt and scale.
Strong Network Effects
International provider collaboration, billions of daily clinical cases, ongoing outcomes capture = fast-growing valuable datasets.

Market Validation

Trusted globally by leading clinics, research groups, and digital health programs.
"RegenMed shared our strategic vision, and was the natural partner to help us design and expand this broad initiative."
Director, Clinical Operations. ROSM
"The platform accommodated our specific research objectives, customer engagement and feedback have been overwhelmingly positive."
Clinical Research Director, EmCyte
"It is of particular importance to document treatment options and their successes. RegenMed provides an excellent platform for this."
Co-Founder, BetaKlinik (Germany)

Recent Developments & Resources

A snapshot of RegenMed’s latest progress, milestones, and educational materials.

Frequently Asked Questions

Got questions? So did many of our investors.
What if the company doesn’t meet its funding goal?

Your investment is only processed if the minimum funding threshold is met.

Can I change my mind after investing?

Yes — federal regulations allow a cancellation window. Here’s how it works.

When do I get my investment back?

Early-stage investing is long-term. This is about owning a piece of the future — not a quick flip.

Join The Discussion

A snapshot of RegenMed’s latest progress, milestones, and educational materials.
Scroll Up Arrow